Inflammatory cell accumulation was significantly decreased in G-1-treated C57BL/6 mice compared to non-treated controls. by Masamichi Itoga (706167)

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Figure S1 - Docosahexaenoic Acid Decreases Pro-Inflammatory Mediators in an <i>In Vitro</i> Murine Adipocyte Macrophage Co-Culture Model by Anna A. De Boer (510740)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

KOR-agonist (U50'488) and MOR-agonist (DAMGO) decrease symptoms in OVA-allergic mice. by Swantje C. Duncker (154707)

Relative Aggrecan mRNA expression levels, as measured by qPCR, in lentiviral-transduced control cells and 5 AggKD cell lines confirm decreased Aggrecan expression in the AggKD cell... by Juanita K. Hodax (6848540)

LD- and haplotype-based measures of epistasis identify a narrow time window of epistasis detectability. by Gabriele Pedruzzi (5753792)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on survival, body weight and body temperature within 48 hours after cecal ligation and puncture (CL... by Daniel Siegl (717509)

Conceptual framework showing the potential relationships of socioeconomic (i.e., social assets, local ecological knowledge, financial assets) and biophysical attributes (i.e., mark... by Marlene Soriano (582736)

The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from... by Meihui Chen (1670020)

Subjects:

Heatmap showing the end motifs of ucfDNA among different groups. by Meihui Chen (1670020)

Subjects:

ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples wi... by Meihui Chen (1670020)

Subjects:

Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice. by Meihui Chen (1670020)

Subjects:

DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i>^-/- and <i>Dnase1</i>^<i>-/-</i> mice with quantifiable ucfDNA using Qubit assay. by Meihui Chen (1670020)

Subjects:

Overview of the study design. by Meihui Chen (1670020)

Subjects:

The end density of ucfDNA across different tissue types. by Meihui Chen (1670020)

Subjects:

End density of the ucfDNA fragments within the DHSs. by Meihui Chen (1670020)

Subjects:

Percentages of ucfDNA fragments starting with T. by Meihui Chen (1670020)

Subjects:

S8 Fig - by Meihui Chen (1670020)

Subjects:

DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i>^-/- and <i>Dnase1</i>^-/- mice. by Meihui Chen (1670020)

Subjects: